Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02961868Not ApplicableCompleted

Cohort Follow-up of Patients With Renal or Craniocervical Fibromuscular Dysplasia

Role: collaborator

NCT02884141Completed

Cross-sectional Study of Patients With Renal or Craniocervical Fibromuscular Dysplasia

Role: collaborator

NCT02701855Unknown

Retina Microvascular Remodeling and Cognitive Function In Hypertension

Role: collaborator

NCT00746902Phase 3Completed

Study of the Relationships Between Refractory Hypertension, Overweight/Obesity and Sleep Apnea Syndrome

Role: collaborator

All 4 trials loaded